Facebook
Twitter
LinkedIn
ForwardUniversity of Pittsburgh School of Pharmacy Spring 2023 Preceptor Continuing Education Seminar - Clinical and Legal Considerations for Cannabis
Use of medical marijuana (cannabis) is becoming more common, and healthcare providers need to understand the pharmacology behind its use, the clinical concerns, safety, as well as approved medical conditions. Legal implications exist as well, and providers need to know the practical considerations with risks and benefits of medical cannabis.
Clinical and Legal Considerations for Cannabis
Tuesday, May 23rd @ 6pm – 8pm
- 6:00pm: Welcome and Introductions
- 6:05pm-6:50pm: Overview of the Clinical Considerations for Cannabis
- Christine Roussel, PharmD, BCOP, BCSCP, Senior Executive Director, Pharmacy, Laboratory and Medical Research, Doylestown Health
- 6:55pm-7:45pm: Understanding the Legal Considerations for Cannabis
- Christine Roussel, PharmD, BCOP, BCSCP
- 7:45pm-7:55pm: Questions and Answers
- 7:55pm: Session Wrap-Up
Target Audience
Nurse
Nurse Practitioner
Pharmacist
Physician
Physician Assistant
Learning Objectives
1. Describe key features of the endocannabinoid system and cannabis pharmacology, and non-phytocannabinoid constitutes of cannabis; including pharmacokinetics and formulations.
2. Describe adverse effects of cannabis use and distinguish clinical concerns associated with selected interactions involving medical marijuana use.
3. Discuss best practices in patient evaluation, medical marijuana product choice, dosage and therapeutic monitoring based on the patient’s serious medical condition; Discuss risk versus benefits including recognition of potential drug interactions, side effects, potential use disorder.
4. Explain the status of cannabis as a controlled substance under U.S. federal law and the provisions of Pennsylvania's Medical Marijuana Act of 2016.
5. Review practice implications of the most current proposed USP cannabis monograph.
6. Have informed discussions with patients about the risks and benefits of medical cannabis for the Pennsylvania approved serious medical conditions
Additional Information
| Attachment | Size |
|---|---|
 Pitt Pharmacy Preceptor CE Spring 2023 final.docx | 428.68 KB |
 Pitt 5.2023 Clinical and Legal Cannabis.pdf | 3.95 MB |
Use of medical marijuana (cannabis) is becoming more common, and healthcare providers need to understand the pharmacology behind its use, the clinical concerns, safety, as well as approved medical conditions. Legal implications exist as well, and providers need to know the practical considerations with risks and benefits of medical cannabis.
Clinical and Legal Considerations for Cannabis
Tuesday, May 23rd @ 6pm – 8pm
- 6:00pm: Welcome and Introductions
- 6:05pm-6:50pm: Overview of the Clinical Considerations for Cannabis
- Christine Roussel, PharmD, BCOP, BCSCP, Senior Executive Director, Pharmacy, Laboratory and Medical Research, Doylestown Health
- 6:55pm-7:45pm: Understanding the Legal Considerations for Cannabis
- Christine Roussel, PharmD, BCOP, BCSCP
- 7:45pm-7:55pm: Questions and Answers
- 7:55pm: Session Wrap-Up
Christine Roussel, PharmD, BCOP, BCSCP, Senior Executive Director, Pharmacy, Laboratory and Medical Research, Doylestown Health
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (ACPE)
The maximum number of hours awarded for this Continuing Pharmacy Education activity is 2.0 contact hours.
JA4008223-0000-23-189-L03-P (Law)
JA4008223-0000-23-190-L01-P (Drug Therapy)
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 2.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
- 2.00 Attendance